Evidence receipt / evaluation
Published · transcript-backedBen Gilbert: evaluation
22 Jan 2024 Acquired Novo Nordisk (Ozempic)
“In many ways, this entire old system that we created that consumes 18% of our GDP may actually not make sense in this new world of treating the things that are more likely to kill us now, which is chronic illnesses.”
Source trail
Everything needed to verify it.
- Speaker
- Ben Gilbert
- Attribution
- Verified speaker
- Claim type
- evaluation
- Recorded
- 22 Jan 2024
- Publisher
- Acquired
- Episode
- Novo Nordisk (Ozempic)
Transcript context
…Right. We made it to the moon. Human quality of life is just unbelievably high, and there's very little in common today on the list of things that will kill you versus 1850. It's completely different set of things. The next frontier then is chronic illnesses. They catch up with us later in life, and they're basically undetectable for the first 50 years or the first 30 years. Obesity leading to Diabetes or cardiovascular, health leading to heart attacks and strokes. These are very different things to treat and require a very different way of thinking, of regulating, of paying for. You don't want to wait until people are sick to treat it because then it's too late. In many ways, this entire old system that we created that consumes 18% of our GDP may actually not make sense in this new world of treating the things that are more likely to kill us now, which is chronic illnesses. I don't really know what to do with that. I think it's pretty interesting. You did so much more of this side of the research than I did. Did you get a sense in talking to people that that transition is happening or no?…
Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.